Observational studyJournal of the American Heart Association2018

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.

Tymon Pol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.